Demographic and clinical characteristics of the controls, not treated with lactoferrin, and patients treated with lactoferrin 4 hours before amniocentesis (LF treated).
Characteristics
Controls ()
LF treated ()
value
Maternal age (years)
36.5 (35.0–38.0)
37.0 (36.0–40.0)
0.061
Gestational age at amniocentesis (weeks)
16.99 (16.44–17.60)
16.91 (16.02–17.66)
0.576
Ethnicity (% ())
0.063
White/Caucasian
93 (53)
81 (44)
Other
7 (4)
19 (10)
Pregestation BMI
21 (20–26)
21 (20–25)
0.687
Postgestation BMI
24 (20–27)
24 (20–26)
0.473
Primiparous (% ())
65% (37)
55% (30)
0.367
Gestational age at delivery (weeks)
40.2 (39.3–40.7)
39.7 (38.5–40.7)
0.097
Creatinine (mg/dL)
0.83 (0.52–1.03)
1.17 (0.81–1.95)
Data are expressed as median (interquartile range). BMI: Body Mass Index; value of chi-square for ethnicity: ; value of chi-square for primiparous: .
